ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
26.24 USD
-0.96 (-3.53%)
ENOV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of ENOV while its profitability can be described as average. ENOV is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
ENOV had positive earnings in the past year.
In the past year ENOV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
ENOV has a Return On Assets of -30.84%. This is comparable to the rest of the industry: ENOV outperforms 42.93% of its industry peers.
ENOV has a Return On Equity (-67.66%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 0.12%, ENOV is in the better half of the industry, outperforming 64.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ENOV has a Operating Margin of 0.25%. This is in the better half of the industry: ENOV outperforms 64.67% of its industry peers.
ENOV's Operating Margin has declined in the last couple of years.
ENOV's Gross Margin of 57.19% is in line compared to the rest of the industry. ENOV outperforms 55.98% of its industry peers.
ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENOV is destroying value.
Compared to 1 year ago, ENOV has more shares outstanding
The number of shares outstanding for ENOV has been increased compared to 5 years ago.
The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
ENOV has an Altman-Z score of 0.79. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
ENOV has a Altman-Z score (0.79) which is in line with its industry peers.
ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
ENOV has a Debt to FCF ratio of 59.72. This is in the better half of the industry: ENOV outperforms 67.39% of its industry peers.
ENOV has a Debt/Equity ratio of 0.66. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
ENOV's Debt to Equity ratio of 0.66 is on the low side compared to the rest of the industry. ENOV is outperformed by 64.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.79 |
ROIC/WACC0.02
WACC7.25%
2.3 Liquidity
ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.22, ENOV perfoms like the industry average, outperforming 41.85% of the companies in the same industry.
ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, ENOV is doing worse than 71.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 26.14% over the past year.
Measured over the past years, ENOV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.18% on average per year.
Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
The Revenue has been decreasing by -8.73% on average over the past years.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
ENOV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.19% yearly.
ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.87% yearly.
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
ENOV is valuated cheaply with a Price/Earnings ratio of 7.88.
Based on the Price/Earnings ratio, ENOV is valued cheaper than 95.65% of the companies in the same industry.
ENOV is valuated cheaply when we compare the Price/Earnings ratio to 26.61, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.47, the valuation of ENOV can be described as very cheap.
ENOV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 98.37% of the companies in the same industry.
ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.01.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.88 | ||
| Fwd PE | 7.47 |
4.2 Price Multiples
ENOV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ENOV is cheaper than 91.85% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than 71.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 65.92 | ||
| EV/EBITDA | 9.69 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y11.4%
EPS Next 3Y11.38%
5. Dividend
5.1 Amount
No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:ENOV (12/23/2025, 2:48:52 PM)
26.24
-0.96 (-3.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.5%
Inst Owner Change-2.38%
Ins Owners1.2%
Ins Owner Change0.81%
Market Cap1.50B
Revenue(TTM)2.23B
Net Income(TTM)-1.37B
Analysts83.75
Price Target49.07 (87%)
Short Float %14.97%
Short Ratio10.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.55%
Min EPS beat(2)7.76%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)8.22%
Min EPS beat(4)4.97%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)7.21%
EPS beat(12)12
Avg EPS beat(12)8.15%
EPS beat(16)16
Avg EPS beat(16)8.66%
Revenue beat(2)0
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.81%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)5
Avg Revenue beat(16)-4.71%
PT rev (1m)-7.03%
PT rev (3m)-11.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.55%
EPS NY rev (1m)1.75%
EPS NY rev (3m)1.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.34%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.88 | ||
| Fwd PE | 7.47 | ||
| P/S | 0.67 | ||
| P/FCF | 65.92 | ||
| P/OCF | 6.91 | ||
| P/B | 0.74 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.69 |
EPS(TTM)3.33
EY12.69%
EPS(NY)3.51
Fwd EY13.39%
FCF(TTM)0.4
FCFY1.52%
OCF(TTM)3.8
OCFY14.47%
SpS39.05
BVpS35.33
TBVpS-8.37
PEG (NY)0.54
PEG (5Y)N/A
Graham Number51.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROCE | 0.15% | ||
| ROIC | 0.12% | ||
| ROICexc | 0.12% | ||
| ROICexgc | 0.34% | ||
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% | ||
| FCFM | 1.02% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-45.54%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.8%
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
F-Score4
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Debt/EBITDA | 4.5 | ||
| Cap/Depr | 66.6% | ||
| Cap/Sales | 8.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 0.79 |
F-Score4
WACC7.25%
ROIC/WACC0.02
Cap/Depr(3y)55.91%
Cap/Depr(5y)50.8%
Cap/Sales(3y)7.49%
Cap/Sales(5y)6.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
EPS Next Y14.56%
EPS Next 2Y11.4%
EPS Next 3Y11.38%
EPS Next 5Y23.19%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
Revenue Next Year7.42%
Revenue Next 2Y5.98%
Revenue Next 3Y5.8%
Revenue Next 5Y8.87%
EBIT growth 1Y-35.24%
EBIT growth 3YN/A
EBIT growth 5Y-48.51%
EBIT Next Year76.5%
EBIT Next 3Y28.12%
EBIT Next 5Y28.11%
FCF growth 1Y122.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y609.06%
OCF growth 3Y-31.69%
OCF growth 5Y-2.82%
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
Can you provide the valuation status for ENOVIS CORP?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.56% in the next year.